SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-142091
Filing Date
2015-04-22
Accepted
2015-04-22 16:47:44
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d845883d20f.htm 20-F 1247247
2 EX-12.1 d845883dex121.htm EX-12.1 5985
3 EX-12.2 d845883dex122.htm EX-12.2 5976
4 EX-13.1 d845883dex131.htm EX-13.1 4404
5 EX-15.1 d845883dex151.htm EX-15.1 1286
6 GRAPHIC g845883tx_pg39.jpg GRAPHIC 140742
7 GRAPHIC g845883tx_pg40a.jpg GRAPHIC 33192
8 GRAPHIC g845883tx_pg40b.jpg GRAPHIC 6372
9 GRAPHIC g845883tx_pg42.jpg GRAPHIC 26243
10 GRAPHIC g845883tx_pg43a.jpg GRAPHIC 48150
11 GRAPHIC g845883tx_pg43b.jpg GRAPHIC 11505
12 GRAPHIC g845883tx_pg46a.jpg GRAPHIC 22622
13 GRAPHIC g845883tx_pg46b.jpg GRAPHIC 33804
14 GRAPHIC g845883tx_pg47a.jpg GRAPHIC 14572
15 GRAPHIC g845883tx_pg47b.jpg GRAPHIC 9963
  Complete submission text file 0001193125-15-142091.txt   1745772
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)85 4 89 49 32
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36622 | Film No.: 15786123
SIC: 2834 Pharmaceutical Preparations